Conversa Health is a leading virtual care and communication platform that delivers personalized, automated patient engagement.
Conversa enables healthcare organizations to virtually engage, monitor and manage patients more effectively and efficiently than ever before, leading to significant clinical and operational benefits.
Conversa Health was founded in 2014 by West Shell III and Philip Marshall. The company is headquartered in Portland, Oregon, with offices in New York, North Carolina and California.
Conversa's technology delivers capacity improvements to help organizations virtually manage, monitor and engage with their health consumers at scale more efficiency than ever before.
Conversa offers Conversa Connect™, a proprietary patient profiling and health signals engine, and the company's extensive library of over 1,000 clinically intelligent conversation programs, that enables healthcare organizations to serve automated, personalized doctor-patient conversation experiences around chronic condition management, post-hospital discharge, pre- and post-surgery, medication adherence, consumer health education and lifestyle health coaching.
Conversa has become the healthcare industry’s virtual health care and communications solution accelerating several key strategic initiatives for Northwell Health, University Hospitals, UCSF, UNC Health, El Camino Health, Allscripts, and many other healthcare organizations.
Conversa is backed by Builders VC, Northwell Ventures, P5 Health Ventures, Nassau Street Ventures, UH Ventures and others. The company raised $12M in Series B round on June 11, 2020. This brings Conversa's total funding to $25.5M to date.